---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-21-003010"
form_type: "8-K"
ticker: "CNBX"
cik: "0001343009"
company_name: "CNBX Pharmaceuticals Inc."
filed_at: "2021-07-19T23:59:59+00:00"
generated_at: "2026-06-30T04:25:51.244381+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Cannabics Pharmaceuticals appoints Dr. Gil Feiler as Independent Board Member

## Summary
- Dr. Gil Feiler appointed as Independent Board Member effective July 15, 2021.
- Feiler brings 25+ years executive experience; director of Bank of Georgia, former board member of First International Bank of Israel.
- Feiler also heads company's Advisory Board; holds BA, MA, and PhD from Tel Aviv University.
- Appointment made by Board resolution; no other changes to board or management disclosed.

## SEC filing metadata
- accession: 0001683168-21-003010
- form_type: 8-K
- ticker: CNBX
- cik: 0001343009
- company_name: CNBX Pharmaceuticals Inc.
- filed_at: 2021-07-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1343009/000168316821003010/0001683168-21-003010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1343009/000168316821003010/cannabics_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-21-003010
- JSON: https://secwatch.observer/filing/0001683168-21-003010.json
- Plain text: https://secwatch.observer/filing/0001683168-21-003010.txt

## Key facts
- Executive change
  Dr. Gil Feiler was appointed as Independent Board Member at CNBX Pharmaceuticals Inc..
  - Action: appointed
  - Role: Independent Board Member
  source text: On July 15th, 2021, the Board of Directors appointed Dr. Gil Feiler as an Independent Board Member
  evidence_url: https://www.sec.gov/Archives/edgar/data/1343009/000168316821003010/0001683168-21-003010-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.